7Baggers
 Mesoblast appoints James O’Brien as CFO  TipRanks Mon, 17 Nov 2025 16:43:59 GMT
 Mesoblast Limited Appoints James M. O?Brien as Chief Financial Officer  MarketScreener Mon, 17 Nov 2025 15:26:49 GMT
 Mesoblast appoints James M. O’Brien as US-based CFO  Seeking Alpha Mon, 17 Nov 2025 07:32:41 GMT
 James M. O’Brien Appointed Chief Financial Officer at Mesoblast  The Manila Times Mon, 17 Nov 2025 07:12:48 GMT
 Mesoblast appoints James M. O'Brien as U.S.-based CFO  MarketScreener Mon, 17 Nov 2025 01:48:20 GMT
 Mesoblast Appoints New CFO Amidst Commercial Transition  TipRanks Mon, 17 Nov 2025 01:42:03 GMT
 Mesoblast Appoints New US Chief Financial Officer  Sharecafe Sun, 16 Nov 2025 23:45:49 GMT
 published on: 2025-11-12 05:49:27  newser.com Wed, 12 Nov 2025 11:49:27 GMT
 Mesoblast Limited (ASX:MSB): Are Analysts Optimistic?  Yahoo Finance Wed, 12 Nov 2025 01:58:00 GMT
 published on: 2025-11-11 05:49:26  newser.com Tue, 11 Nov 2025 11:49:26 GMT
 published on: 2025-11-11 02:11:47  newser.com Tue, 11 Nov 2025 08:11:47 GMT
 mesoblast shares surge 60% in a year. have investors missed the boat?  The Motley Fool Australia Tue, 11 Nov 2025 01:47:35 GMT
 published on: 2025-11-06 05:21:32  newser.com Thu, 06 Nov 2025 11:21:32 GMT
 mesoblast to meet us fda on opioid cessation data for back pain drug  MarketScreener Wed, 05 Nov 2025 09:54:32 GMT
 mesoblast to discuss opioid reduction data with fda  TipRanks Wed, 05 Nov 2025 00:59:06 GMT
 Mesoblast to meet FDA on opioid reduction data from Rexlemestrocel-L Phase 3 trial  Proactive financial news Wed, 05 Nov 2025 00:41:38 GMT
 published on: 2025-11-04 02:24:06  newser.com Tue, 04 Nov 2025 08:24:06 GMT
 Mesoblast to Discuss Opioid Reduction Data with FDA  TipRanks Tue, 04 Nov 2025 08:00:00 GMT

Mesoblast Limited
(NASDAQ:MESO) 

MESO stock logo

Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine...

Founded: 2004
Full Time Employees: 102
CEO: Silviu Itescu  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends